nodes	percent_of_prediction	percent_of_DWPC	metapath
Carprofen—PTGS2—ovarian follicle—polycystic ovary syndrome	0.128	0.383	CbGeAlD
Carprofen—PTGS2—Nicotinate metabolism—NMNAT3—polycystic ovary syndrome	0.0592	0.109	CbGpPWpGaD
Carprofen—Naproxen—AKR1C3—polycystic ovary syndrome	0.0463	0.388	CrCbGaD
Carprofen—Ibuprofen—PLAT—polycystic ovary syndrome	0.0386	0.323	CrCbGaD
Carprofen—PTGS2—Nicotinamide salvaging—NAMPT—polycystic ovary syndrome	0.0369	0.0677	CbGpPWpGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0223	0.0409	CbGpPWpGaD
Carprofen—Ibuprofen—BCL2—polycystic ovary syndrome	0.0222	0.186	CrCbGaD
Carprofen—PTGS2—Nicotinate metabolism—NAMPT—polycystic ovary syndrome	0.0197	0.036	CbGpPWpGaD
Carprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.019	0.0349	CbGpPWpGaD
Carprofen—PTGS2—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0177	0.0325	CbGpPWpGaD
Carprofen—PTGS2—embryo—polycystic ovary syndrome	0.0174	0.0518	CbGeAlD
Carprofen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.0151	0.0277	CbGpPWpGaD
Carprofen—PTGS2—adrenal cortex—polycystic ovary syndrome	0.0142	0.0424	CbGeAlD
Carprofen—PTGS1—endometrium—polycystic ovary syndrome	0.0133	0.0397	CbGeAlD
Carprofen—PTGS2—endometrium—polycystic ovary syndrome	0.0127	0.0379	CbGeAlD
Carprofen—Ibuprofen—PPARG—polycystic ovary syndrome	0.0123	0.103	CrCbGaD
Carprofen—PTGS1—uterus—polycystic ovary syndrome	0.0122	0.0365	CbGeAlD
Carprofen—PTGS1—pituitary gland—polycystic ovary syndrome	0.012	0.0359	CbGeAlD
Carprofen—PTGS1—adipose tissue—polycystic ovary syndrome	0.012	0.0357	CbGeAlD
Carprofen—PTGS2—uterus—polycystic ovary syndrome	0.0117	0.0349	CbGeAlD
Carprofen—PTGS2—pituitary gland—polycystic ovary syndrome	0.0115	0.0343	CbGeAlD
Carprofen—PTGS2—adipose tissue—polycystic ovary syndrome	0.0114	0.0342	CbGeAlD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.0113	0.0208	CbGpPWpGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.011	0.0201	CbGpPWpGaD
Carprofen—PTGS1—adrenal gland—polycystic ovary syndrome	0.0107	0.0321	CbGeAlD
Carprofen—PTGS2—adrenal gland—polycystic ovary syndrome	0.0103	0.0306	CbGeAlD
Carprofen—PTGS1—female gonad—polycystic ovary syndrome	0.01	0.0299	CbGeAlD
Carprofen—PTGS1—vagina—polycystic ovary syndrome	0.00995	0.0297	CbGeAlD
Carprofen—PTGS1—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00963	0.0176	CbGpPWpGaD
Carprofen—PTGS2—female gonad—polycystic ovary syndrome	0.00957	0.0286	CbGeAlD
Carprofen—PTGS2—vagina—polycystic ovary syndrome	0.00952	0.0284	CbGeAlD
Carprofen—PTGS1—endocrine gland—polycystic ovary syndrome	0.00931	0.0278	CbGeAlD
Carprofen—PTGS2—endocrine gland—polycystic ovary syndrome	0.0089	0.0266	CbGeAlD
Carprofen—PTGS2—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.00883	0.0162	CbGpPWpGaD
Carprofen—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.0087	0.0159	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00831	0.0152	CbGpPWpGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00818	0.015	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00764	0.014	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00688	0.0126	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—polycystic ovary syndrome	0.00676	0.0124	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00659	0.0121	CbGpPWpGaD
Carprofen—PTGS2—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00649	0.0119	CbGpPWpGaD
Carprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.00628	0.0115	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00586	0.0107	CbGpPWpGaD
Carprofen—PTGS2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00546	0.01	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0051	0.00935	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00474	0.0087	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00465	0.00853	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00461	0.00844	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00432	0.00792	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00418	0.00767	CbGpPWpGaD
Carprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.00414	0.0076	CbGpPWpGaD
Carprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.004	0.00733	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00396	0.00727	CbGpPWpGaD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00376	0.00689	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00375	0.00688	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00367	0.00672	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00366	0.0067	CbGpPWpGaD
Carprofen—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00348	0.00638	CbGpPWpGaD
Carprofen—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00343	0.00628	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00316	0.0058	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00315	0.00577	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00306	0.00561	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00303	0.00556	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00303	0.00555	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00298	0.00547	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.0029	0.00532	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00288	0.00527	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00271	0.00497	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.0027	0.00494	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00263	0.00482	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00259	0.00475	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00256	0.0047	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00252	0.00462	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00244	0.00447	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00241	0.00442	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00239	0.00438	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00231	0.00423	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0023	0.00421	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0023	0.00421	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00226	0.00414	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00219	0.00402	CbGpPWpGaD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00205	0.00376	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00204	0.00373	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00203	0.00373	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00199	0.00366	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00193	0.00355	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00192	0.00353	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00188	0.00345	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00187	0.00343	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00182	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00182	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00182	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00182	0.00334	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00174	0.00319	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00172	0.00315	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00162	0.00296	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00161	0.00295	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00153	0.0028	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.0015	0.00274	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00149	0.00272	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00148	0.00271	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00145	0.00265	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.00142	0.0026	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00142	0.0026	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00141	0.00259	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00138	0.00253	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00135	0.00247	CbGpPWpGaD
Carprofen—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.00134	0.00246	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00132	0.00242	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00129	0.00237	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.00129	0.00237	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00128	0.00234	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00121	0.00221	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.0012	0.0022	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.0012	0.0022	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00118	0.00215	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00117	0.00215	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00113	0.00206	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00112	0.00206	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.0011	0.00201	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00107	0.00196	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00105	0.00192	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00105	0.00192	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00104	0.00191	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.00103	0.00188	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.00103	0.00188	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.00102	0.00187	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00102	0.00187	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00101	0.00186	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000983	0.0018	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000968	0.00177	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000957	0.00175	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000954	0.00175	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000933	0.00171	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00089	0.00163	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000871	0.0016	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000857	0.00157	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000842	0.00154	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000826	0.00151	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000812	0.00149	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000812	0.00149	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000812	0.00149	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000803	0.00147	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00078	0.00143	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000775	0.00142	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000768	0.00141	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000766	0.0014	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000735	0.00135	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000707	0.0013	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000691	0.00127	CbGpPWpGaD
Carprofen—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.00069	0.00127	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.00068	0.00125	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000659	0.00121	CbGpPWpGaD
Carprofen—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000655	0.0012	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000651	0.00119	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000645	0.00118	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000617	0.00113	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000615	0.00113	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000608	0.00111	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000601	0.0011	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000587	0.00108	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000569	0.00104	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000559	0.00102	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00055	0.00101	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000548	0.001	CbGpPWpGaD
Carprofen—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000539	0.000988	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000523	0.000959	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000523	0.000959	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000517	0.000948	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000507	0.000929	CbGpPWpGaD
Carprofen—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.0005	0.000917	CbGpPWpGaD
Carprofen—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000496	0.000909	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00049	0.000898	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000489	0.000896	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000477	0.000874	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000469	0.00086	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000467	0.000855	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000466	0.000854	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000464	0.00085	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00046	0.000844	CbGpPWpGaD
Carprofen—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000457	0.000837	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000451	0.000827	CbGpPWpGaD
Carprofen—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000445	0.000816	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000438	0.000802	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000431	0.00079	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000415	0.000762	CbGpPWpGaD
Carprofen—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000415	0.000761	CbGpPWpGaD
Carprofen—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000408	0.000749	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000402	0.000738	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000388	0.000711	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000373	0.000684	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000373	0.000683	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00037	0.000679	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000368	0.000675	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000365	0.00067	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000363	0.000665	CbGpPWpGaD
Carprofen—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.00035	0.000641	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000348	0.000637	CbGpPWpGaD
Carprofen—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000344	0.00063	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000342	0.000627	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000341	0.000625	CbGpPWpGaD
Carprofen—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000328	0.000601	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000304	0.000558	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000296	0.000543	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.00029	0.000532	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000288	0.000528	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000275	0.000504	CbGpPWpGaD
Carprofen—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000275	0.000504	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000271	0.000496	CbGpPWpGaD
Carprofen—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.00027	0.000495	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000256	0.00047	CbGpPWpGaD
Carprofen—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000243	0.000445	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000242	0.000443	CbGpPWpGaD
Carprofen—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.000231	0.000424	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.00023	0.000422	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000218	0.0004	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000208	0.000381	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000205	0.000376	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.000204	0.000374	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.000203	0.000373	CbGpPWpGaD
Carprofen—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.000202	0.00037	CbGpPWpGaD
Carprofen—PTGS2—Disease—INS—polycystic ovary syndrome	0.000193	0.000354	CbGpPWpGaD
Carprofen—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.000187	0.000342	CbGpPWpGaD
Carprofen—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000177	0.000325	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	0.000165	0.000302	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—POMC—polycystic ovary syndrome	0.000163	0.000298	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—INS—polycystic ovary syndrome	0.000162	0.000297	CbGpPWpGaD
Carprofen—PTGS2—Disease—IL6—polycystic ovary syndrome	8.44e-05	0.000155	CbGpPWpGaD
